SXC sells pharmacy benefit management (PBM) services to U.S. businesses to process and pay prescription drug claims. SXC went public in a reverse takeover in 1997, when it raised $10 million. Since then, its revenues have soared, to $5 billion in 2011, up from $1.9 billion in 2010. The company’s earnings increased as well, to $166.4 million in 2011, up 45% over the previous year, and its shares have returned 630% over the last three years. With more than 1,200 employees, SXC established itself with funding and support from venture capitalists, investment bankers, analysts, brokers and institutional fund managers, a venture financing structure unique to the Canadian marketplace.